Navigation Links
Novel Diagnostic Marker for Acute Kidney Injury Previewed at Abbott-Sponsored Scientific Workshop
Date:7/29/2008

by a nephrologist and a third will go on dialysis. "Clinically, there is no comparison since NGAL provides specific and rapid diagnosis of AKI while creatinine blood tests are not able to distinguish AKI from chronic kidney disease," Devarajan said.

"From the single drop of urine, we obtain essential information when time is critical to help prevent kidney failure and save lives. With close monitoring, the early information provided by the NGAL test could make treatments more effective if started at the beginning of AKI," he said.

Devarajan presented his findings during a symposium at AACC titled Translational Medicine and the Clinical Laboratory: Emerging Biomarkers for Acute Kidney Injury. The marker has been the subject of recent articles published in Lancet, Annals of Internal Medicine and the Clinical Journal of the American Society of Nephrology. Devarajan's research was supported, in part, by a restricted research grant from Abbott.

Abbott is developing a unique urine NGAL test and has initiated international clinical trials.

About Abbott's Diagnostics Businesses

Abbott is a global leader in in vitro diagnostics and offers a broad range of innovative instrument systems and tests for hospitals, reference labs, molecular labs, blood banks, physician offices and clinics. With more than 65,000 institutional customers in more than 100 countries, Abbott's diagnostic products offer customers automation, convenience, bedside testing, cost effectiveness and flexibility. Abbott has helped transform the practice of medical diagnosis from an art to a science through the company's commitment to improving patient care and lowering costs. Abbott's history is filled with examples of first-of-a-kind diagnostic products and significant technological and research advancements.

About Abbott

Abbott is a global, broad-based health care company devoted to the discovery, development, manufacture and marketing of pharmaceuticals and m
'/>"/>

SOURCE Abbott
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. Novel 3-D cell culture model shows selective tumour uptake of nanoparticles
2. Novel virus detection identifies new viruses in study of respiratory infections and asthma attacks
3. Researchers uncover novel mechanism that balances the sizes of functional areas in the brain
4. Novel Cooling Therapy May Have Aided Injured Football Player
5. ECLIPSE data on effects of Otsukas investigational novel treatment, Tolvaptan
6. SNM seeks novel approaches to molecular imaging to showcase at annual meeting
7. GrantAdler Shipping Novel Implantable Vascular Access Port
8. SNM seeks novel approaches to molecular imaging to showcase at annual meeting
9. Novel strategy under study for aggressive leukemia
10. ISTO Technologies Receives 510(k) Clearance for a Novel Bone Graft Substitute and Bone Graft Extender
11. 454 Sequencing(TM): Science Paper Describes a Novel, Highly Efficient Method of Sequencing Ancient DNA; Sequences the Mitochondria of 10 Individual Mammoths to Prove It
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/27/2014)... (PRWEB) August 27, 2014 AttorneyOne.com, a ... all the latest information from the FDA on ... on August 1, that Organic Raw Carob Powder sold ... recalled due to possible contamination with Salmonella. ... with weakened immune systems. In healthy people it can ...
(Date:8/27/2014)... Hospitals and health systems can have ... one they add brings the challenge of additional integration ... manage. Kaweah Delta Health Care District is moving in ... vendors who offer full-featured solutions that are easy to ... Delta selected Access to provide electronic forms and ...
(Date:8/27/2014)... New York (PRWEB) August 27, 2014 ... inclusion in the 2015 edition of The Best Lawyers ... Law - Plaintiffs," and "Personal Injury Litigation - Plaintiffs." ... and is a summa cum laude graduate of Syracuse ... professor and authors the "Civil Practice" chapter of the ...
(Date:8/27/2014)... *Anyone who is interested in learning more about the clinical ... on the web ( http://www.availclinical.com ) or contact them directly at ... by fibromyalgia – a condition characterized by a broad range ... pain , Joint stiffness , Muscle ... Depression , Anxiety , While no ...
(Date:8/26/2014)... (PRWEB) August 27, 2014 Emerging and ... relevant and useful to those they serve – which ... Wickstrom’s blog at http://www.PerWickstrom.com and read his ... Help Leaders Maintain their Edge.” , “Leadership ... permanent and can therefore be assumed,” commented Per Wickstrom, ...
Breaking Medicine News(10 mins):Health News:Organic Raw Carob Powder by Sunburst SuperFoods Recalled: AttorneyOne Monitors and Keeps Consumers Informed 2Health News:Kaweah Delta Health Care District Selects Access to Provide Paperless E-Forms and Electronic Patient Signatures 2Health News:Kaweah Delta Health Care District Selects Access to Provide Paperless E-Forms and Electronic Patient Signatures 3Health News:Michael A. Bottar Selected For Inclusion In The Best Lawyers In America© 2015 2Health News:Avail Clinical Research is Looking for Qualified Individuals Who Are Interested in Participating in a Fibromyalgia Clinical Trial Near Orlando, Florida 2Health News:Avail Clinical Research is Looking for Qualified Individuals Who Are Interested in Participating in a Fibromyalgia Clinical Trial Near Orlando, Florida 3Health News:Per Wickstrom’s Latest Blog Post Provides 10 Tips to Help Leaders Maintain their Edge 2
... Chongqing Bureau of Health, BLOOMINGTON, Minn., ... is hosting the first major medical,delegation of ... their,three-month stay, the physicians will observe hospital- ... and hospital administration and,observe clinical research methodology., ...
... 5pm Today, LAWRENCE, Mass., May 12 NxStage ... innovative dialysis products,today announced its financial results for the ... first quarter of 2008 were $31.0 million, compared to,$8.4 ... million in the fourth,quarter of 2007. Revenues in the ...
... mice, drug prevented heart failure in those with Duchenne ... Patients with Duchenne muscular dystrophy often suffer from heart ... of this condition, a new Canadian study finds. , ... improved heart performance by preventing the breakdown of a ...
... Tort reform,s lasting impact and other influences are limiting the ... of frequency ... Corporation (NYSE: AOC ),the leading provider of global risk ... the long term care industry,finding for the first time in ...
... May 12 /Xinhua-PRNewswire-FirstCall/ -- Tianyin,Pharmaceutical, Co., Inc., (OTC ... traditional Chinese medicine ("TCM") based in,Chengdu, China, today ... Third,Annual China Discovery Tour on Tuesday, May 20, ... be held at the Regent Hotel in Beijing, ...
... Inc. (Nasdaq: GTIV ), the nation,s leading provider ... scheduled to,present from 2:30 p.m. to 2:55 p.m. ET, ... Global Health Care Conference in New York., The ... live audio web,cast, which may be accessed by visiting, ...
Cached Medicine News:Health News:First Major Chinese Medical Delegation Visits Minnesota 2Health News:NxStage Medical Reports First Quarter 2008 Results 2Health News:NxStage Medical Reports First Quarter 2008 Results 3Health News:NxStage Medical Reports First Quarter 2008 Results 4Health News:NxStage Medical Reports First Quarter 2008 Results 5Health News:NxStage Medical Reports First Quarter 2008 Results 6Health News:NxStage Medical Reports First Quarter 2008 Results 7Health News:NxStage Medical Reports First Quarter 2008 Results 8Health News:NxStage Medical Reports First Quarter 2008 Results 9Health News:NxStage Medical Reports First Quarter 2008 Results 10Health News:NxStage Medical Reports First Quarter 2008 Results 11Health News:Viagra May Protect Hearts of Some Muscular Dystrophy Patients 2Health News:Aon Study Finds Stability in Nationwide Liability Costs in the Long Term Health Care Sector 2Health News:Aon Study Finds Stability in Nationwide Liability Costs in the Long Term Health Care Sector 3Health News:Tianyin Pharmaceutical to Present at Roth Third Annual China Discovery Tour in Beijing on May 20, 2008 at 12:40 p.m. Beijing Time 2Health News:Gentiva(R) Health Services to Present May 21 at 2008 Citi Investment Research Global Health Care Conference in New York 2Health News:Gentiva(R) Health Services to Present May 21 at 2008 Citi Investment Research Global Health Care Conference in New York 3
(Date:8/26/2014)... MOUNTAIN VIEW, Calif. , Aug. 26, 2014  Based ... Frost & Sullivan recognizes Volpara Solutions with the 2014 North ... Solutions offers an innovative range of volumetric breast imaging solutions ... few years, the company has steadily introduced several new solutions ... the United States , Europe , ...
(Date:8/26/2014)... -- Novira Therapeutics, Inc., a privately held biopharmaceutical company ... B virus (HBV) infection, today announced that Roger ... of its Scientific Advisory Board (SAB). In this role ... the Company.  "We are thrilled to ... Christian Schade , Chief Executive Officer at Novira.  "Roger ...
(Date:8/26/2014)... 26, 2014  Zimmer Holdings, Inc. (NYSE and SIX: ZMH), ... Board of Directors has approved the payment of a quarterly ... The cash dividend of $0.22 per share ... stockholders of record as of the close of business on ... approval of the Board of Directors and may be adjusted ...
Breaking Medicine Technology:Frost & Sullivan Applauds Volpara Solutions' Clear Vision in Identifying the Importance of Dose Tracking and Quantitative Analytics in the Early Detection of Breast Cancer 2Frost & Sullivan Applauds Volpara Solutions' Clear Vision in Identifying the Importance of Dose Tracking and Quantitative Analytics in the Early Detection of Breast Cancer 3Frost & Sullivan Applauds Volpara Solutions' Clear Vision in Identifying the Importance of Dose Tracking and Quantitative Analytics in the Early Detection of Breast Cancer 4Frost & Sullivan Applauds Volpara Solutions' Clear Vision in Identifying the Importance of Dose Tracking and Quantitative Analytics in the Early Detection of Breast Cancer 5Novira Therapeutics Announces Appointment of Roger J. Pomerantz, M.D., F.A.C.P., as Chair of Scientific Advisory Board 2Novira Therapeutics Announces Appointment of Roger J. Pomerantz, M.D., F.A.C.P., as Chair of Scientific Advisory Board 3Novira Therapeutics Announces Appointment of Roger J. Pomerantz, M.D., F.A.C.P., as Chair of Scientific Advisory Board 4
... 2011 BD (Becton, Dickinson and Company) ... technology company, announced today that it is donating $325,000 ... earthquake and tsunami in Japan. BD will distribute these ... AmeriCares, American Red Cross, Direct Relief International, Heart to ...
... March 15, 2011 New Image Global, Inc., ... recently joined forces with the disability advocacy group, ... donated artificial limbs to candidates disabled by amputation ... manufacturing facility in Santiago, Dominican Republic.) Under the ...
Cached Medicine Technology:BD Donates $325,000 for Japan Earthquake and Tsunami Relief Efforts 2
Simple straight stem design for the low-demand patient....
The Perfecta PDA components provide the design and material choice imperative in today's cost conscious medical climate....
The P.S.L. stem is manufactured from cobalt chrome and is available with or without porous coating to give the surgeon the option of utilizing either the cementless of cemented technique at his or he...
The proximally modular S-ROM Total Hip System provides custom capability at non-custom prices and is competitive with conventional porous coated systems....
Medicine Products: